Data and materials availability
All data are available in the main text and the supplementary materials.
References
Hay JR, Johnson VE, Young AM, Smith DH, Stewart W (2015) Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans. J Neuropathol Exp Neurol 74:1147–1157. https://doi.org/10.1097/NEN.0000000000000261
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C et al (2020) Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 382:2268–2270. https://doi.org/10.1056/NEJMc2008597
Jaunmuktane Z, Mahadeva U, Green A, Sekhawat V, Barrett NA, Childs L et al (2020) Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19. Acta Neuropathol 140:397–400. https://doi.org/10.1007/s00401-020-02190-2
Krasemann S, Haferkamp U, Pfefferle S, Woo MS, Heinrich F, Schweizer M et al (2022) The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Reports 17:307–320. https://doi.org/10.1016/j.stemcr.2021.12.011
Lee MH, Perl DP, Nair G, Li W, Maric D, Murray H et al (2021) Microvascular Injury in the Brains of Patients with COVID-19. N Engl J Med 384:481–483. https://doi.org/10.1056/NEJMc2033369
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al (2020) Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 77:683–690. https://doi.org/10.1001/jamaneurol.2020.1127
McAlpine LS, Fesharaki-Zadeh A, Spudich S (2021) Coronavirus disease 2019 and neurodegenerative disease: what will the future bring? Curr Opin Psychiatry 34:177–185. https://doi.org/10.1097/YCO.0000000000000688
Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ (2021) Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management. J Am Heart Assoc. https://doi.org/10.1161/JAHA.120.019650
Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK et al (2021) The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci 24:368–378. https://doi.org/10.1038/s41593-020-00771-8
Smith DH, Dolle JP, Ameen-Ali KE, Bretzin A, Cortes E, Crary JF et al (2021) COllaborative Neuropathology NEtwork Characterizing ouTcomes of TBI (CONNECT-TBI). Acta Neuropathol Commun 9:32. https://doi.org/10.1186/s40478-021-01122-9
Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS et al (2020) Neuropathological Features of COVID-19. N Engl J Med 383:989–992. https://doi.org/10.1056/NEJMc2019373
Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK et al (2022) SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612:758–763. https://doi.org/10.1038/s41586-022-05542-y
Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133–150. https://doi.org/10.1038/nrneurol.2017.188
Thakur KT, Miller EH, Glendinning MD, Al-Dalahmah O, Banu MA, Boehme AK et al (2021) COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain 144:2696–2708. https://doi.org/10.1093/brain/awab148
Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q et al (2021) SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther 6:337. https://doi.org/10.1038/s41392-021-00719-9
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Acknowledgements
Here, we thank the NINDS/ NIA-supported Center Without Walls, CONNECT-TBI, and Center for Neurodegenerative Disease Research (CNDR) for providing the brain tissue sections, particularly Aimee M. Schantz, John Campos, Theresa Schuck, and John L. Robinson for their coordination. We acknowledge the Penn Tumor Tissue and Biospecimen Bank for providing the lung tissue sections. We also appreciate Comparative Pathology Core at University of Pennsylvania and particularly Dr. Charles-Antoine Assenmacher for helping with whole slide scanning using Aperio VERSA 200 platform.
Funding
This research was made available with the following support from National Institutes of Health grant U54NS115322 (DHS and WS), National Institutes of Aging grants U19AG062418 (Virginia M.-Y. Lee), P30AG072979 (EBL) and P01AG066597 (EBL), and Nancy and Buster Alvord Endowment (CDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Each author’s contributions to the paper are listed. Conceptualization: HS, DHS. Methodology: HS, AT, KKA, DLS, SMS, JPD, VEJ, BM, EBL, AN, CDK, WS, DHS. Investigation: HS, KKA, DLS, DHS. Visualization: HS, DLS. Funding acquisition: WS, DHS. Supervision: HS, SMS, JPD, VEJ, EBL, CDK, SRW, WS, DHS. Writing—original draft: HS, DHS. Writing—review and editing: HS, WS, DHS.
Corresponding author
Ethics declarations
Conflict of interest
EBL is the member of the Editorial Board for Acta Neuropathologica, but was not involved in the editorial handling of this article. Other authors declare no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. Tissue was obtained from the following Institutions: University of Washington, University of Glasgow, and University of Pennsylvania. Tissue was acquired at routine diagnostic autopsy, and approval for its use was granted by the respective institutional review boards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Song, H., Tomasevich, A., Acheampong, K.K. et al. Detection of blood–brain barrier disruption in brains of patients with COVID-19, but no evidence of brain penetration by SARS-CoV-2. Acta Neuropathol 146, 771–775 (2023). https://doi.org/10.1007/s00401-023-02624-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-023-02624-7